Loading...

A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials

INTRODUCTION: The target glycated haemoglobin (HbA1c) at which micro- and macrovascular benefits may be derived in type 2 diabetes (T2D) has never been clearly outlined. This meta-analysis was conducted on 15 randomized controlled trials to highlight the association of HbA1c range with outcomes. MET...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Ther
Main Authors: Sinha, Binayak, Ghosal, Samit
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8179883/
https://ncbi.nlm.nih.gov/pubmed/33895981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-01062-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!